Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: A double-blind, randomized, placebo-controlled study

European Journal of Pain

Volumn 13, Issue 5, 2009, Pages 492-496

  Carbone, Mario ^a   Pentenero, Monica ^a   Carrozzo, Marco ^b   Ippolito, Alessio ^a   Gandolfo, Sergio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Alpha lipoic acid (ALA); Burning mouth syndrome; Therapy

Indexed keywords

PLACEBO; THIOCTIC ACID; VITAMIN;

ABSENCE OF SIDE EFFECTS; ARTICLE; BURNING MOUTH SYNDROME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

AGED; BURNING MOUTH SYNDROME; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN THRESHOLD; PLACEBO EFFECT; PLACEBOS; PROSPECTIVE STUDIES; THIOCTIC ACID; TREATMENT FAILURE; VITAMIN B COMPLEX;

EID: 63549084965     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2008.06.004     Document Type: Article

References (23)

1. Bergdahl J., Anneroth G., and Perris H. Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study. J Oral Pathol Med 24 (1995) 213-215
2. Bogetto F., Maina G., Ferro G., Carbone M., and Gandolfo S. Psychiatric comorbidity in patients with burning mouth syndrome. Psychosom Med 60 (1998) 378-385
3. Femiano F. Burning mouth syndrome (BMS): an open trial of comparative efficacy of alpha-lipoic acid (thioctic acid) with other therapies. Minerva Stomatol 51 (2002) 405-409
4. Femiano F., and Scully C. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy. J Oral Pathol Med 31 (2002) 267-269
5. Femiano F., Gombos F., Scully C., Busciolano M., and De Luca P. Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology. Oral Dis 6 (2000) 274-277
6. Femiano F., Gombos F., and Scully C. Burning mouth syndrome: open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy. Med Oral 9 (2004) 8-13
7. Femiano F., Gombos F., and Scully C. Burning mouth syndrome: the efficacy of lipoic acid on subgroups. J Eur Acad Dermatol Venereol 18 (2004) 676-678
8. Gremeau-Richard C., Woda A., Navez M.L., Attal N., Bouhassira D., Gagnieu M.C., et al. Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain 108 (2004) 51-57
9. Grushka M., Sessle B.J., and Miller R. Pain and personality profiles in burning mouth syndrome. Pain 28 (1987) 155-167
10. Headache Classification Subcommittee. The International Classification of Headache Disorders: 2nd ed. Cephalalgia 2004;24(Suppl. 1):9-160.
11. Maina G., Vitalucci A., Gandolfo S., and Bogetto F. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatr 63 (2002) 38-43
12. Maina G., Albert U., Gandolfo S., Vitalucci A., and Bogetto F. Personality disorders in patients with burning mouth syndrome. J Personal Disord 19 (2005) 84-93
13. McQuay H.J., and Moore R.A. Placebo. Postgrad Med J 81 (2005) 155-160
14. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1 (1975) 277-299
15. Osaki T., Yoneda K., Yamamoto T., Ueta E., and Kimura T. Candidiasis may induce glossodynia without objective manifestation. Am J Med Sci 319 (2000) 100-105
16. Patton L.L., Siegel M.A., Benoliel R., and De Laat A. Management of burning mouth syndrome: systematic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 Suppl. S39 (2007) e1-e13
17. Petrovic P., Kalso E., Petersson K.M., and Ingvar M. Placebo and opioid analgesia - imaging a shared neuronal network. Science 295 (2002) 1737-1740
18. Pisanty S., Rafaely B., and Polshuk W. The effects of steroid hormones on buccal mucosa of menopausal women. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 40 (1975) 346-353
19. Sardella A., Uglietti D., Demarosi F., Lodi G., Bez C., and Carrassi A. Benzydamine hydrochloride oral rinses in management of burning mouth syndrome. A clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88 (1999) 683-686
20. Satoh T. Clinical and fundamental investigations on recurrent glossodynia. Nippon Ishinkin Gakkai Zasshi 45 (2004) 233-237
21. Scala A., Checchi L., Montevecchi M., Marini I., and Giamberardino M.A. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 14 (2003) 275-291
22. Tammiala-Salonen T., and Forssell H. Trazodone in burning mouth pain: a placebo-controlled, double-blind study. J Orofac Pain 13 (1999) 83-88
23. Zakrzewska J.M., Forssell H., and Glenny A.M. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev (2005) CD002779